Karen Soares is CLO at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). They have made 4 open-market trades across 1 company since 2025, most recently 2026-09-15.
CIK 0001999086
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLOV | 1,607,371 | $7.2M |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLOV | SELL | 2026-09-15 | 2026-09-15 | $4.78 | $33K | -5.4% | -1.4% | — |
| CLOV | SELL · 10b5-1 | 2026-07-20 | 2026-07-20 | $4.51 | $233K | -6.2% | -8.3% | — |
| CLOV | SELL | 2026-07-15 | 2026-07-16 | $4.67 | $49K | -0.2% | -1.4% | +10.1% |
| CLOV | SELL | 2026-06-15 | 2026-06-16 | $4.61 | $22K | +8.8% | -10.0% | +4.1% |
| CLOV | SELL | 2025-03-06 | 2025-03-07 | $3.80 | $200K | +6.0% | -8.3% | -13.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.